Searching for GLP-1 weight loss care near you should lead to a licensed clinical evaluation, not an automatic prescription. Good care begins with medical history, current medicines, goals, and safety screening. It also includes a clear follow-up plan and transparent costs.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Trademark notice: Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.
Important safety information: Each branded medicine named above carries a boxed warning about the risk of thyroid C-cell tumors and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Serious risks can include pancreatitis, gallbladder disease, kidney injury associated with dehydration, severe gastrointestinal reactions, and serious allergic reactions. Risks differ by product and patient. Review the official prescribing information for Zepbound, Mounjaro, Ozempic, and Wegovy.
Local care can include telehealth
"Near me" does not always require a trip to a clinic. Telehealth may provide access to a clinician who is licensed in the state where the patient is located. Whether remote care is appropriate depends on the patient's needs and the clinician's judgment. Some concerns may require an in-person exam, testing, or urgent care.
Ask who will perform the evaluation and verify that person's professional license through the state licensing board. Confirm how follow-up visits work, how messages are handled, and who responds if side effects develop. A program should explain when it directs patients to local or emergency care.
Convenience matters, but continuity matters too. A service that provides access only until a payment clears does not provide ongoing clinical care.
What a clinical evaluation should cover
A clinician may review medical conditions, prior treatment, allergies, pregnancy plans, eating-disorder history, gastrointestinal concerns, and medicines that could affect safety. The clinician may request records, measurements, or lab work when appropriate. The exact evaluation varies by patient.
No reputable program can guarantee eligibility before that review. A search result, questionnaire, or payment does not establish that a prescription is medically appropriate. If treatment begins, follow-up should address tolerance, adherence, new symptoms, and any changes in health or medication.
Ask how the care team communicates with the patient's primary care or other clinicians when coordination is needed. Clear roles reduce gaps in care.
Approved prescription options
Some FDA-approved prescription medicines act through GLP-1 pathways and have specific labeled uses. The choice among them is a clinical decision based on the individual and the current prescribing information. Insurance formularies and pharmacy availability are separate practical issues and should not drive unsafe prescribing.
When an approved medicine is discussed, ask for the official Medication Guide and Instructions for Use. Review contraindications, warnings, common reactions, storage, and administration with the clinician or pharmacist. Seek urgent help for severe or rapidly worsening symptoms.
A program should never promise weight loss or describe an expected result as certain. Response and tolerability vary, and continuing care should be individualized.
Compounded GLP-1 products are separate
A compounded product must be clearly identified by its active ingredient. It is not an approved brand, generic version, or interchangeable product. Brand and compounded choices should not be blended into one offer or comparison row.
Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality. Compounded semaglutide or compounded tirzepatide is not Zepbound, Mounjaro, Ozempic or Wegovy, and is not a generic or interchangeable version of any approved drug. It may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, from a state-licensed pharmacy.
Ask for the dispensing pharmacy's name before committing to care. Verify the pharmacy with the state board of pharmacy. The prescription label should identify the active ingredient, concentration, directions, beyond-use date, and pharmacy. Ask the pharmacist about storage, shipping, and administration before use.
Body Good's service fee, when applicable, covers the clinical program described during intake. Medication cost is separate and is not included. The pharmacy sets and collects its medication charge. The service fee is not an individual quote, and clinician evaluation determines eligibility.
Compare programs beyond location
Use the same checklist for an office nearby and a telehealth program:
- Is the clinician licensed where the patient will be located?
- Is there a real clinical evaluation before any prescription decision?
- Can the patient contact the care team between scheduled visits?
- Is the dispensing pharmacy identified and state licensed?
- Are approved and compounded medicines described in separate sections?
- Are medication charges separate from clinical service fees?
- Does the program explain cancellation and refund terms?
- Is there a plan for urgent symptoms and care coordination?
Avoid programs that guarantee a prescription, promise a specific result, conceal the pharmacy, or use an approved brand name to market a compounded product. A low headline price may exclude medication, labs, supplies, or follow-up.
Insurance and self-pay questions
If insurance may be used, ask the plan about the exact prescribed product, labeled use, prior authorization, deductible, pharmacy network, and member cost. The plan decides coverage and payment. Coverage support can help check benefits and prepare requested documentation, but it cannot guarantee approval.
For self-pay care, request separate written amounts for the clinical service and medication. Ask which charges are one-time and which recur. Confirm that the pharmacy, not the clinic website, dispenses and charges for medication.
Body Good's care pathway
Body Good provides clinical evaluation and ongoing program support. A licensed clinician reviews submitted information and determines whether any treatment is appropriate. Services may include follow-up, coverage support, and pharmacy coordination. No prescription, insurance outcome, medication availability, or weight result is guaranteed.
This website provides information and a pricing overview only. It takes no payment, collects no protected health information, and runs no intake form. All checkout and intake happen on the separate secure site. Begin Body Good's clinical intake to provide information for review.
Trademark and safety information
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.
Important safety information: Each branded medicine named above carries a boxed warning about the risk of thyroid C-cell tumors. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Serious risks can include pancreatitis, gallbladder disease, kidney injury associated with dehydration, severe gastrointestinal reactions, and serious allergic reactions. Risks vary by product. Read the official prescribing information for Zepbound, Mounjaro, Ozempic, and Wegovy.
FAQ
Is telehealth GLP-1 care considered local care?
It can be when the clinician is licensed in the state where the patient is located and telehealth is appropriate for the situation. Some needs still require in-person care.
Should a program promise a prescription after payment?
No. A licensed clinician must first evaluate the patient. Payment or intake completion does not guarantee eligibility or a prescription.
Is medication included in Body Good's service fee?
No. The service fee covers the clinical program described during intake. A pharmacy charges separately for any prescribed medication.